Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Early Stage Breast Cancer (Stage 1-3) × Anthracyclines × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Triple Negative Breast Neoplasms 2 Leukemia, Myeloid, Acute 2 Cardiotoxicity 2 Pathologic Complete Response 1 Neoplasms, Second Primary 1 Leukemia 1 Cardiovascular Diseases 1 Breast Cancer Early Stage Breast Cancer (Stage 1-3) 1

Interventions

fezolinetant 1 Therapeutics 1 Immune Checkpoint Inhibitors 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07317778 2026-01-05

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡